Determining the mechanism and impact of streptococcal RaS-RiPPs on the human oral microbiome
Project Number4R00DE032311-02
Former Number1K99DE032311-01A1
Contact PI/Project LeaderRUED, BRITTA
Awardee OrganizationIOWA STATE UNIVERSITY
Description
Abstract Text
PROJECT SUMMARY
The human oral microbiome is home to a unique group of bacteria with the ability to affect the overall
health of the human host: Streptococci spp. This group is involved in a wide range of diseases, from dental
caries to infective endocarditis. They include important oral pathogens such as the cariogenic Streptococcus
mutans and commensal organisms such as Streptococcus mitis. These important oral members produce a
large array of radical-S-adenosylmethionine ribosomally synthesized and post-translationally modified peptides
(RaS-RiPPs). The newly identified compounds include a wealth of chemical structures and have been found to
inhibit the growth of other oral Streptococci, as well as modulate the behavior of producer organisms
themselves. The initial goal of this proposal is to elucidate the mechanism of action of the RaS-RiPP tryglysin
from S. mutans, and to examine its impact on the functional oral microbiome. Upon defining tryglysin’s
mechanism of action on oral Streptococci and the oral microbiome, this study will be expanded to examine the
biological significance of other RaS-RiPPs produced by Streptococci: streptosactin, suisactin, rotapeptides,
and NxxC family peptides. While the chemical structure and synthesis of these peptides has been defined, the
biological significance of these identified RaS-RiPPs is unexplored. Given the important status of Streptococci
spp. to the health of the human oral microbiota, this represents a major gap in knowledge about a class of
peptides with huge potential impacts on overall oral health. This proposal aims to create a research platform
for studying RaS-RiPPs from oral Streptococci, defining their function, and examining shifts in the functional
oral microbiome in response to their production. Executing this research program at the University of Illinois at
Chicago (UIC) will allow for the establishment of the candidate as an independent researcher and provide
avenues for the achievement of the candidate’s career goals: establishing a productive and first-rate research
laboratory and securing a tenured faculty position at a major research institution.
Public Health Relevance Statement
PROJECT NARRATIVE
This project aims to define the function and biological significance of a class of peptides (RaS-RiPPs)
produced by oral Streptococci, and to examine their impact on the human oral microbiota. Understanding how
these compounds modulate the oral microbiome and the activity of their own host species represents an
important gap in knowledge concerning one of the major groups of oral microorganisms. In turn, these data will
provide a foundation for examining their impact on the host and oral niche.
National Institute of Dental and Craniofacial Research
CFDA Code
121
DUNS Number
005309844
UEI
DQDBM7FGJPC5
Project Start Date
16-August-2024
Project End Date
15-August-2027
Budget Start Date
16-August-2024
Budget End Date
15-August-2025
Project Funding Information for 2024
Total Funding
$249,000
Direct Costs
$177,893
Indirect Costs
$71,107
Year
Funding IC
FY Total Cost by IC
2024
National Institute of Dental and Craniofacial Research
$249,000
Year
Funding IC
FY Total Cost by IC
Sub Projects
No Sub Projects information available for 4R00DE032311-02
Publications
Publications are associated with projects, but cannot be identified with any particular year of the project or fiscal year of funding. This is due to the continuous and cumulative nature of knowledge generation across the life of a project and the sometimes long and variable publishing timeline. Similarly, for multi-component projects, publications are associated with the parent core project and not with individual sub-projects.
No Publications available for 4R00DE032311-02
Patents
No Patents information available for 4R00DE032311-02
Outcomes
The Project Outcomes shown here are displayed verbatim as submitted by the Principal Investigator (PI) for this award. Any opinions, findings, and conclusions or recommendations expressed are those of the PI and do not necessarily reflect the views of the National Institutes of Health. NIH has not endorsed the content below.
No Outcomes available for 4R00DE032311-02
Clinical Studies
No Clinical Studies information available for 4R00DE032311-02
News and More
Related News Releases
No news release information available for 4R00DE032311-02
History
No Historical information available for 4R00DE032311-02
Similar Projects
No Similar Projects information available for 4R00DE032311-02